Antimicrobial Resistance

Antimicrobial resistance (AMR) is a complex issue of global concern with potentially dramatic health and economic consequences.

The OECD provides countries with the evidence to implement effective and cost-effective One Health policies to tackle AMR, promote effective use of antimicrobials in human and animal health, strengthen infection prevention and control measures, and incentivise research and development in the antibiotic sector.

Our latest report Embracing a One Health Framework to Fight Antimicrobial Resistance has been released on September 14, 2023

LATEST EVENT – European Antibiotic Awareness Day 2023

Fighting-AMR-2023

On the European Antibiotic Awareness Day (EAAD) 2023, the OECD released a new Policy Brief presenting key findings of the latest OECD analysis on antimicrobial resistance (AMR) - Embracing a One Health Framework to Fight Antimicrobial Resistance - for the European Union (EU)/European Economic Area (EEA) countries.
The EAAD is part of the World AMR Awareness Week (18-24 November) that aims to improve awareness and understanding of this public health threat caused by the ability of microbes to resist antimicrobials.

Download the 2023 OECD Policy Brief Fighting Antimicrobial Resistance in EU and EEA countries
Watch Antimicrobial resistance targets: How can we reach them by 2030? To mark the 16th European Antibiotic Awareness Day, ECDC hosted a digital event that brought together experts to discuss antimicrobial resistance (AMR) from a One Health perspective.

Previous documents:

Download the joint OECD-ECDC Briefing Note for EU/EEA Countries to inform the 2022 High-Level One Health Ministerial Meeting on Antimicrobial Resistance (French Presidency of the EU Council, March 2022): Antimicrobial Resistance in the EU/EEA: A One Health Response
Download the joint OECD-ECDC Briefing Note to inform the 2019 EU Health Ministerial Meeting on AMR: Antimicrobial Resistance: Tackling the Burden in the European Union

Key documents on antimicrobial resistance

A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing, Health Policy, Vol. 126, Issue 6, June 2022
Food safety policies and their effectiveness to prevent foodborne diseases in catering establishments: A systematic review and meta-analysis, Food Research International, June 2022
Antimicrobial resistance in long-term care facilities, OECD Health Working Paper No. 136, February 2022
Financial strategies targeting healthcare providers to promote the prudent use of antibiotics: a systematic review of the evidence, International Journal of Antimicrobial Agents, December 2021
Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis, Clinical and Experimental Vaccine Research, May 2021
Stemming the Superbug Tide - Just a Few Dollars More, November 2018

G7 WORK ON AMR

The G7 has consistently committed to tackling global health challenges, including the fight against infectious diseases, and positioned itself as a leading partner in reaching health-related Millennium Development Goals, by initiating and supporting many global instruments of response to threats posed by infectious diseases.

In 2022, the German Presidency of the G7 commissioned OECD and WHO a joint briefing paper on addressing the burden of infections and antimicrobial resistance associated with healthcare, with a focus on G7 Countries. Findings in the report assess the level of implementation of infection prevention and control policies both in G7 countries and globally to make a strong economic case for scaling up action.

Read the full report: Addressing the burden of infections and antimicrobial resistance associated with healthcare – Focus on G7 countries (available on October 18, 14h00 CET)

In 2015, the OECD released a first report to support G7 action in the area of AMR:

Read the full report: Antimicrobial Resistance in G7 Countries and Beyond - Economic Issues, Policies and Options for Action
Policy Brief on Antimicrobial resistance in G7 countries and beyond

G20 WORK ON AMR

Read the note prepared for the G20 by OECD along with WHO, FAO and OIE, on potential strategies to tackle antimicrobial resistance (AMR) and ensure sustainable research and development (R&D) for new antibiotics. The note calls for action based on a coordinated and cross-sectoral approach under the ‘One Health’ framework, highlights the urgent need to address barriers to innovation and suggests policy and governance mechanisms to reactivate the antibiotic R&D pipeline.

In the Hamburg G20 declaration, leaders called for a new R&D Collaboration Hub and committed to further examine practical market incentive options, in collaboration with relevant experts including from the OECD and the WHO.

Also AvailableEgalement disponible(s)